COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics to Host R&D Day on Tuesday, June 19, 2018
08/06/2018
-- Event to be Webcast Live – CAMBRIDGE, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of [...]
Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10
08/06/2018
Biohit Oyj: Notice pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10 Biohit Oyj STOCK EXCHANGE RELEASE June 8, 2018 at 3.30 PM Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, [...]
Biohit Oyj: Managers' Transactions
08/06/2018
Biohit Oyj: Managers' Transactions BIOHIT Oyj MANAGERS’ TRANSACTIONS 8 JUNE 2018 3.15 P.M. Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Vesa Suovaniemi Estate Position: Closely [...]
Biohit Oyj: Managers' Transactions
08/06/2018
Biohit Oyj: Managers' Transactions BIOHIT OYJ MANAGERS’ TRANSACTIONS 8 JUNE 2018 3.15 P.M. Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Suovaniemi, Osmo Position: Member of the [...]
The American Health Council Selects Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to Industry Board
08/06/2018
NEW YORK, June 08, 2018 (GLOBE NEWSWIRE) -- The American Health Council selected Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to its Industry Board. Currently the senior clinical pharmacist specialist at [...]
Biohit Oyj: Managers' Transactions
08/06/2018
Biohit Oyj: Managers' Transactions BIOHIT Oyj MANAGERS’ TRANSACTIONS 8 JUNE 2018 3.00 P.M. Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Suovaniemi, Oili Position: Closely [...]
Samumed Announces Multiple Presentations at the European League Against Rheumatism (EULAR) 2018 Annual Congress
08/06/2018
SAN DIEGO, June 08, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it will present clinical and preclinical data on two of the company’s investigational drugs, SM04690, for the treatment of osteoarthritis ( [...]
Selecta Biosciences to Present Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at EULAR 2018
08/06/2018
WATERTOWN, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
Incysus Therapeutics Scientific Co-Founder Lawrence Lamb, PhD to Present at 8th International Gamma-Delta T Cell Conference
08/06/2018
Symposium Title: “ Targeting of chemotherapy-induced NKG2DL by localized repetitive γδ T cell infusions: a rational therapeutic design for elimination of minimal residual primary high grade gliomas” NEW YORK, June 08, [...]
Biohit Oyj: Managers' Transactions
08/06/2018
Biohit Oyj: Managers' Transactions BIOHIT Oyj MANAGERS’ TRANSACTIONS 8 JUNE 2018 P.M. 2.40 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Interlab Oy Position: Closely Associated [...]
Solon Eiendom ASA : Primary insider notification
08/06/2018
(Oslo, Norway, June 08, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 40.000 shares at a price of NOK 30.0091 and through his wholly owned company [...]
Terveystalo Plc: Changes in the Composition of Shareholders' Nomination Board
08/06/2018
Terveystalo Plc Stock Exchange release 8 June 2018 at 14:35 p.m. EEST The Helsinki Deaconess Institute has appointed Laura Raitio as its new representative for Terveystalo's Shareholders' Nomination Board, replacing [...]
Surface Oncology to Present at Goldman Sachs 39th Annual Global Healthcare Conference
08/06/2018
CAMBRIDGE, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Assembly Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08/06/2018
INDIANAPOLIS and SAN FRANCISCO, June 08, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB) a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis [...]
G1 Therapeutics Announces Appointment of New Members to the Board of Directors
08/06/2018
RESEARCH TRIANGLE PARK, N.C., June 08, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that Cynthia Schwalm and Willie Deese have been appointed to its [...]
Fennec Announces Results of Annual Meeting
08/06/2018
RESEARCH TRIANGLE PARK, N.C., June 08, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April [...]
Amicus Therapeutics Appoints President and COO Bradley L. Campbell to Board of Directors
08/06/2018
Directors Donald J. Hayden, Jr. and Craig A. Wheeler Re-Elected CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company focused on discovering, developing and [...]
XORTX Announces Filing of FDA pre-IND Meeting Request Letter
08/06/2018
CALGARY, Alberta, June 08, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Emergent BioSolutions to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
08/06/2018
GAITHERSBURG, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will present a corporate overview and discuss recent [...]

Pages